Scientific Reports (Aug 2024)

Investigating the WNT and TGF-beta pathways alterations and tumor mutation burden in young-onset colorectal cancer

  • Morgan Ferrell,
  • Deniz Can Guven,
  • Cyndi Gonzalez Gomez,
  • Elham Nasrollahi,
  • Richard Giza,
  • Svea Cheng,
  • Masood Pasha Syed,
  • Tara Magge,
  • Aatur Singhi,
  • Anwaar Saeed,
  • Turcin Saridogan,
  • Ibrahim Halil Sahin

DOI
https://doi.org/10.1038/s41598-024-68938-y
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Colorectal cancer (CRC) is the third most common cancer in the United States. Recent epidemiological evidence demonstrates an increasing incidence of young-onset CRC cases, defined as CRC cases in individuals 50 years old or younger. Studies have established that alterations in both the WNT and TGF-Beta signaling pathways have contributed to CRC development. While this is well understood, the comprehensive analysis of WNT and TGF-Beta pathway alterations in young-onset CRC cases has yet to be investigated. Here, we conducted a comprehensive bioinformatics analysis of mutations associated with each of the WNT and TGF-Beta signaling pathways according to age (≤ 50 years old versus > 50 years old) utilizing published genomic data from the cBioPortal. Chi-square results demonstrated no significant difference in WNT alterations between young-onset CRC and those > 50 years old. However, across all age groups, WNT alterations were frequently found in rectal cancers. We also found that WNT alterations were associated with better outcomes. The mutations associated with TGF-beta were observed at a higher rate in older CRC patients when compared to those ≤ 50 years old. Additionally, these mutations were found more frequently in colon primaries.